Autopsy and Case Reports
Autopsy and Case Reports
Autopsy Case Report

Sudden death of an egg donor during oocyte retrieval due to ovarian hyperstimulation syndrome

Swati Tyagi; Asit Ranjan Mridha; Chittaranjan Behera

Downloads: 0
Views: 87


Ovarian Hyperstimulation Syndrome (OHSS) is uncommon among oocyte donors during in vitro fertilization (IVF) procedure and is rarely associated with death. We report a case of a 23-year-old oocyte donor who suddenly died on the operation table during oocyte retrieval. She had no risk factors in her menstrual history, laboratory, or clinical parameters. The antagonist cycle, triggered with the GnRH agonist protocol, was carried out. The cause of death at autopsy was attributed to respiratory failure due to acute massive pulmonary edema, which developed due to the complication of OHSS. Only a few autopsy cases associated with OHSS have been published, but, as far as we know, no clinical or autopsy cases of sudden death caused by OHSS have been reported.


Oocyte Donation, Pulmonary Edema, Death, Sudden, Ovarian Hyperstimulation Syndrome


1 Zivi E, Simon A, Laufer N. Ovarian hyperstimulation syndrome: definition,incidence, and classification. Semin Reprod Med. 2010;28(6):441-7. PMid:21082501.

2 Binder H, Dittrich R, Einhaus F, et al. Update on ovarian hyperstimulation syndrome: part 1 - incidence and pathogenesis. Int J Fertil Womens Med. 2007;52(1):11-26. PMid:17987884.

3 Selter J, Wen T, Palmerola KL, Friedman AM, Williams Z, Forman EJ. Life-threatening complications among women with severe ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 2019;220(6):575.e1-11. PMid:30742828.

4 Sauer MV. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases. Am J Obstet Gynecol. 2001;184(3):277-8. PMid:11228473.

5 Maxwell KN, Cholst IN, Rosenwaks Z. The incidence of both serious and minor complications in young women undergoing oocyte donation. Fertil Steril. 2008;90(6):2165-71. PMid:18249368.

6 Balen A. Ovarian hyperstimulation syndrome: a short report for the HFEA. London: UK Parliament; 2005 [cited 2022 Mar 3]. Available from:

7 Mozes M, Bogokowsky H, Antebi E, et al. Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet. 1965;286(7424):1213-5. PMid:4158825.

8 Fineschi V, Neri M, Di Donato S, Pomara C, Riezzo I, Turillazzi E. An immunohistochemical study in a fatality due to ovarian hyperstimulation syndrome. Int J Legal Med. 2006;120(5):293-9. PMid:16741744.

9 Semba S, Moriya T, Youssef EM, Sasano H. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol Int. 2000;50(7):549-52. PMid:10886738.

10 Cluroe AD, Synek BJ. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology. 1995;27(4):344-6. PMid:8771153.

11 Pooniya S, Behera C, Mridha AR, Bhardwaj DN, Millo T. Fatal ovarian hyperstimulation syndrome in an anonymous egg donor. Med Leg J. 2016;84(4):219-23. PMid:27542392.

12 Ludwig M, Tölg R, Richardt G, Katus HA, Diedrich K. Myocardial infarction associated with ovarian hyperstimulation syndrome. JAMA. 1999;282(7):632-3. PMid:10517713.

13 Akdemir R, Uyan C, Emiroglu Y. Acute myocardial infarction secondary thrombosis associated with ovarial hyperstimulation syndrome. Int J Cardiol. 2002;83(2):187-9. PMid:12007695.

14 Coli S, Magnoni M, Melisurgo G, et al. Myocardial infarction complicating the initial phase of an ovarian stimulation protocol. Int J Cardiol. 2007;115(1):E56-7. PMid:17067704.

15 Ravel P, Marcaggi X, Ferrier N, et al. Myocardial infarction and ovarian stimulation: case report. Ann Cardiol Angeiol. 2009;58(5):313-7. PMid:19819419.

16 Wang N, Chen Z, Guo X, et al. Sudden death due to severe ovarian hyperstimulation syndrome: an autopsy-centric case report. Am J Forensic Med Pathol. 2021;42(1):88-91. PMid:33186129.

17 Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management. Kidney Int. 2017;92(1):37-46. PMid:28318633.

18 Thomsen L, Humaidan P. Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin. Curr Opin Obstet Gynecol. 2015;27(3):210-4. PMid:25811256.

19 Blumenfeld Z. The ovarian hyperstimulation syndrome. Vitam Horm. 2018;107:423-51. PMid:29544639.

20 Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 1988;159(1):210-5. PMid:3134814.

21 Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV Jr. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod. 1994;9(5):792-9. PMid:7929724.

22 Mahajan N, Gupta S, Sharma S, Rani K, Naidu P, Arora PR. Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis. J Hum Reprod Sci. 2015;8(4):234-8. PMid:26752860.

23 Saha PK, Goel P, Tandon R. Ovarian hyperstimulation syndrome (OHSS) presented as massive hydrothorax. J Clin Diagn Res. 2013;7(12):2996-7. PMid:24551705.

24 Shmorgun D, Claman P, Gysler M, et al. The diagnosis and management of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can. 2011;33(11):1156-62. PMid:22082791.

Submitted date:

Accepted date:

Publication date:

6290bb34a953953158657fd3 autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections